Key result
SR-BI-null mice challenged with a single dose of LPS experienced 90% fatality within 3 days, whereas 0% of wild-type littermates died, demonstrating SR-BI protects against NO cytotoxicity in vivo.
Why the study?
Does Scavenger Receptor BI (SR-BI) prevent nitric oxide-induced cytotoxicity and endotoxin-induced death in preclinical models?
Does Scavenger Receptor BI (SR-BI) prevent nitric oxide-induced cytotoxicity and endotoxin-induced death in preclinical models?
Absolute Event Rate: 90% vs 0%
Scavenger receptor BI protects against nitric oxide-induced cytotoxicity and endotoxin-induced death in vivo, suggesting a potential therapeutic target for nitric oxidative stress-associated diseases such as septic shock.
Nitric oxide (NO)-induced oxidative stress contributes to a variety of diseases. Although numerous mechanisms have been described controlling the production of NO, the mechanisms to prevent NO-induced cytotoxicity after NO synthesis are largely unknown. Here we report that scavenger receptor BI (SR-BI) prevents NO-induced cytotoxicity. Using CHO cell lines expressing wild-type and single-site mutant SR-BI protein, we demonstrate that SR-BI prevents NO-induced cytotoxicity and that a highly conserved CXXS redox motif is required for the anti-NO cytotoxicity activity of SR-BI. Using genetically manipulated mice, we demonstrate that SR-BI-null mice have a 3- to 4-fold increase in tyrosine nitrated proteins in aorta and liver compared with wild-type littermates, indicating that expression of SR-BI prevents peroxynitrite formation in vivo. Using lipopolysacharide (LPS)-challenged mice as an in vivo model of NO-induced cytotoxicity, we found that a single dose of LPS (120,000 U/g IP) induced 90% fatality of SR-BI-null mice within 3 days, whereas all of the wild-type littermates survived (n=20), demonstrating that SR-BI is highly protective against NO cytotoxicity in vivo. Importantly, SR-BI prevents LPS-induced death without eliminating NO production, suggesting that SR-BI prevents NO-induced cytotoxicity post-NO synthesis. Our study describes a novel observation that may shed new light on the treatment of nitric oxidative stress-associated diseases, such as septic shock.
No takes yet. Share an insight, caveat, or question.
Li et al. (2006) studied Nitric oxide-induced cytotoxicity and endotoxin-induced death. Scavenger receptor BI (SR-BI) null mutation vs. Wild-type littermates was evaluated on Fatality within 3 days after lipopolysaccharide challenge. SR-BI-null mice challenged with a single dose of LPS experienced 90% fatality within 3 days, whereas 0% of wild-type littermates died, demonstrating SR-BI protects against NO cytotoxicity in vivo.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: